Literature DB >> 23821133

Men's experience with sexual dysfunction post-rectal cancer treatment: a qualitative study.

Melinda Ball1, Christian J Nelson, Elyse Shuk, Tatiana D Starr, Larissa Temple, Lina Jandorf, Leslie Schover, John P Mulhall, Heidi Woo, Sabrina Jennings, Katherine DuHamel.   

Abstract

In an effort to address reports from men that their sex life is worse after treatment for rectal cancer, this qualitative study was designed to better understand their experience with sexual dysfunction following rectal cancer treatment, thus providing information on the adaptation of a psycho-educational sexual health intervention for male rectal cancer survivors and simultaneously investigating barriers and promoters that would influence their participation in a psycho-educational sexual health intervention. Thirteen male rectal cancer survivors who were treated at Memorial Sloan-Kettering Cancer Center (MSKCC) for rectal cancer participated (median time post-treatment was 6.4 years). Six survivors participated in individual semi-structured phone interviews, and seven others took part in focus groups. We performed standard procedures of qualitative thematic text analysis, which involved independent review of interview and focus group transcripts by several analysts followed by consensus meetings to identify key themes. Participants reported bowel dysfunction (N = 13, or 100%) and erectile dysfunction (N = 12, or 92%) as chief complaints. The participants thought a psychoeducational sexual health intervention post-surgery would be helpful because it would provide educational information regarding the etiology of their problems and treatments to improve their sexual health (N = 8, or 62%). Most participants' primary concern immediately after treatment was surviving their disease; improving sexual functioning seemed to become more important over time. Barriers to potentially participating in a psycho-educational sexual health intervention included geographical distance from MSKCC (N = 3, or 3/13) and the risk of embarrassment when discussing sexual issues (N = 5, or 5/13). Men reported that a psycho-educational sexual health intervention would be helpful to improve their sexual functioning post-treatment. Discussion of bowel issues and logistical concerns gave information on the psycho-educational sexual health intervention.

Entities:  

Mesh:

Year:  2013        PMID: 23821133      PMCID: PMC3755110          DOI: 10.1007/s13187-013-0492-y

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  30 in total

1.  The use of treatments for erectile dysfunction among survivors of prostate carcinoma.

Authors:  Leslie R Schover; Rachel T Fouladi; Carla L Warneke; Leah Neese; Eric A Klein; Craig Zippe; Patrick A Kupelian
Journal:  Cancer       Date:  2002-12-01       Impact factor: 6.860

2.  Long-term follow-up of patients receiving injection therapy for erectile dysfunction.

Authors:  C P Sundaram; W Thomas; L E Pryor; A A Sidi; K Billups; J L Pryor
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

3.  Improving communication with cancer patients. A challenge for physicians.

Authors:  D Razavi; N Delvaux; P Hopwood
Journal:  Ann N Y Acad Sci       Date:  1997-02-20       Impact factor: 5.691

4.  Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.

Authors:  F Montorsi; G Guazzoni; L F Strambi; L F Da Pozzo; L Nava; L Barbieri; P Rigatti; G Pizzini; A Miani
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

5.  Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer.

Authors:  G H Mannaerts; M P Schijven; A Hendrikx; H Martijn; H J Rutten; T Wiggers
Journal:  Eur J Surg Oncol       Date:  2001-04       Impact factor: 4.424

6.  The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study.

Authors:  A B Araujo; R Durante; H A Feldman; I Goldstein; J B McKinlay
Journal:  Psychosom Med       Date:  1998 Jul-Aug       Impact factor: 4.312

7.  Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions.

Authors:  Stephen J Lepore; Vicki S Helgeson; David T Eton; Richard Schulz
Journal:  Health Psychol       Date:  2003-09       Impact factor: 4.267

8.  Increased incidence of depressive symptoms in men with erectile dysfunction.

Authors:  R Shabsigh; L T Klein; S Seidman; S A Kaplan; B J Lehrhoff; J S Ritter
Journal:  Urology       Date:  1998-11       Impact factor: 2.649

9.  Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Authors:  Arnold L Potosky; William W Davis; Richard M Hoffman; Janet L Stanford; Robert A Stephenson; David F Penson; Linda C Harlan
Journal:  J Natl Cancer Inst       Date:  2004-09-15       Impact factor: 13.506

10.  Doctor-patient communication: results of a four-year prospective study in rectal cancer patients.

Authors:  Jacqueline Kerr; Jutta Engel; Anne Schlesinger-Raab; Hansjörg Sauer; Dieter Hölzel
Journal:  Dis Colon Rectum       Date:  2003-08       Impact factor: 4.585

View more
  9 in total

1.  Role of local excision in the management of rectal cancer: what does the future hold?

Authors:  P A Cataldo
Journal:  Tech Coloproctol       Date:  2016-10-20       Impact factor: 3.781

2.  Barriers to participation in a sexual health intervention for men following treatment for rectal and anal cancer.

Authors:  Kelly M Shaffer; Christian J Nelson; Katherine N DuHamel
Journal:  Psychooncology       Date:  2017-12-19       Impact factor: 3.894

3.  Phosphodiesterase-5 Inhibitors and Vacuum Erection Device for Penile Rehabilitation After Laparoscopic Nerve-Preserving Radical Proctectomy for Rectal Cancer: A Prospective Controlled Trial.

Authors:  Haijun Deng; Dong Liu; Xiangming Mao; Xiaoliang Lan; Hao Liu; Guoxin Li
Journal:  Am J Mens Health       Date:  2016-08-24

Review 4.  American Cancer Society Colorectal Cancer Survivorship Care Guidelines.

Authors:  Khaled El-Shami; Kevin C Oeffinger; Nicole L Erb; Anne Willis; Jennifer K Bretsch; Mandi L Pratt-Chapman; Rachel S Cannady; Sandra L Wong; Johnie Rose; April L Barbour; Kevin D Stein; Katherine B Sharpe; Durado D Brooks; Rebecca L Cowens-Alvarado
Journal:  CA Cancer J Clin       Date:  2015-09-08       Impact factor: 508.702

5.  'Because Everybody is so Different': a qualitative analysis of the lived experiences and information needs of rectal cancer survivors.

Authors:  Catherine H Saunders; Jenaya L Goldwag; Jackson T Read; Marie-Anne Durand; Glyn Elwyn; Srinivas J Ivatury
Journal:  BMJ Open       Date:  2021-05-19       Impact factor: 2.692

6.  Life after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners.

Authors:  Jeffrey A Albaugh; Nat Sufrin; Brittany R Lapin; Jacqueline Petkewicz; Sandi Tenfelde
Journal:  BMC Urol       Date:  2017-06-15       Impact factor: 2.264

7.  Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal study.

Authors:  Jane Frankland; Sally Wheelwright; Natalia V Permyakova; David Wright; Nicole Collaço; Lynn Calman; Jane Winter; Deborah Fenlon; Alison Richardson; Peter W Smith; Claire Foster
Journal:  BMJ Open       Date:  2020-11-12       Impact factor: 2.692

8.  How Should Physicians Respond When Patients Distrust Them Because of Their Gender?

Authors:  Monica Peek; Bernard Lo; Alicia Fernandez
Journal:  AMA J Ethics       Date:  2017-04-01

9.  Patient-reported outcomes and experiences from the perspective of colorectal cancer survivors: meta-synthesis of qualitative studies.

Authors:  Claudia Rutherford; Fabiola Müller; Nasiba Faiz; Madeleine T King; Kate White
Journal:  J Patient Rep Outcomes       Date:  2020-04-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.